Skip to main content
. Author manuscript; available in PMC: 2024 Jan 18.
Published in final edited form as: Alzheimer Dis Assoc Disord. 2023 Jan 18;37(1):20–27. doi: 10.1097/WAD.0000000000000538

TABLE 3.

Adjusted hazards ratios for anticholinergic drug use on developing MCI#

Model 1 Model 2 Model 3
Variable HR (95% CI) P value HR (95% CI) P value HR (95% CI) P value
Age 1.1 (1.1, 1.1) <0.001 1.1 (1.1, 1.1) <0.001 1.1 (1.1, 1.1) <0.001

Female 1.2 (1.0, 1.5) 0.120 1.2 (1.0, 1.5) 0.115 1.2 (1.0, 1.5) 0.121

Education
 < high school Reference Reference Reference
 = high school 0.8 (0.6, 1.0) 0.070 0.8 (0.6, 1.0) 0.067 0.8 (0.6, 1.0) 0.073
 > high school 0.6 (0.4, 0.8) 0.001 0.6 (0.4, 0.8) 0.001 0.6 (0.4, 0.8) 0.001

Total number of prescription medications
 <3 Reference Reference Reference
 3-6 1.1 (0.8, 1.4) 0.608 1.1 (0.8, 1.4) 0.591 1.1 (0.8, 1.4) 0.659
 >6 1.2 (0.9, 1.6) 0.274 1.2 (0.9, 1.7) 0.245 1.1 (0.8, 1.6) 0.469

Take any anticholinergic drug 1.4 (1.0, 1.8) 0.029

Total ACR score
 0 Reference
 1-3 1.4 (1.0, 1.8) 0.026
 >3 1.3 (0.9, 1.8) 0.15
 >3 versus 1-3 # 0.9 (0.7, 1.2) 0.687

Total number of anticholinergic drugs
 0 Reference
 1-2 1.3 (1.0, 1.8) 0.037
 >2 1.5 (1.0, 2.1) 0.037
 >2 versus 1-2 * 1.1 (0.8, 1.4) 0.508

Abbreviations: HR, hazard ratio; CI, confidence interval.

#

MCI was defined as clinical dementia rating (CDR) score =0.5.

#

is comparing total ACR score of >3 to 1-3 (the reference)

*

is comparing total number of anticholinergic drugs of >2 to 1-2 (the reference).

Models 1, 2, 3 used any anticholinergic drug use, total ACR score, total number of anticholinergic drugs as the main predictor, respectively.